THERAPY OF MITOCHONDRIAL INSUFFICIENCY IN UNDIFFERENTIATED FORMS OF CONNECTIVE TISSUE DYSPLASIA IN CHILDREN Russian patent published in 2010 - IPC A61K31/7068 A61K31/194 A61K31/355 A61K31/4415 A61K31/205 A61K33/06 A61K31/495 A61P3/02 

FIELD: medicine.

SUBSTANCE: invention concerns medicine, namely paediatrics, and can be used for treating mitochondrial insufficiency in undifferentiated forms of connective tissue dysplasia in children. That is ensured by the staged introduction of medicine complexes once a year. At the 1st stage, Riboxinum, Limontar and Kudesan are introduced during 1.5 months. At the 2nd stage, Oligovit, Elcar, Magnerot are introduced during 1.5 months. At the 3rd stage, Preductal MV is introduced during 3 months.

EFFECT: higher efficiency of biological processes of cell respiration and oxidative phosphorylation in energy release of organic compounds and ATP production in an organism.

1 dwg, 1 ex